Phase III
The ASCEND Study
- Study HIC#:2000032809
- Last Updated:08/06/2023
This is a study for those 6 years or older to evaluate the efficacy and safety of topical TMB-001 0.05% ointment for 12-24 weeks for the treatment of congenital Ichthyosis.
- Age6 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Nicole Olszewski
- Phone Number: 1-203-785-5505
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
This is a study for those 6 years or older to evaluate the efficacy and safety of topical TMB-001 0.05% ointment for 12-24 weeks for the treatment of congenital Ichthyosis.
Eligibility Criteria
- 6 years or older,
- not pregnant,
- if childbearing age 2 forms of birth control,
- clinical diagnosis of CI based upon phenotype and has a genetic confirmation of either ARCI (including but not exclusively transglutaminase 1-deficient, ALOX-12B) or RXLI (e.g., deletion of steroid sulfatase gene) subtypes of congenital Ichthyosis,
- documented history of moderate to severe disease at Screening,
- subject and parent/guardian (if applicable) are willing and able to apply the study treatment(s) as directed, comply with study instructions, and commit to all follow-up visits for the duration of the study.
Principal Investigator
- Score: 1
